Inventor · disambiguated record
Dale B. Schenk
Also filed as: SCHENK DALE · SCHENK DALE B · SCHENK DALE BERNARD
72 granted patents·54 pending applications·6,208 citations·filing 1986–2024
99Inventor score
Files withNEURALAB LTD43SCHENK DALE B25ELAN PHARM INC16JANSSEN ALZHEIMER IMMUNOTHERAP9ATHENA NEUROSCIENCES INC6
Top patents by PatentIndex Score
126 records- 0199US7014855B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Mar 21, 2006·122 cites·63 claims
- 0299US6972127B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Dec 6, 2005·120 cites·120 claims
- 0399US6913745B1Passive immunization of Alzheimer's diseaseNEURALAB LTD·Filed 2000·Granted Jul 5, 2005·142 cites·60 claims
- 0499US6875434B1Methods of treatment of Alzheimer's diseaseNEURALAB LTD·Filed 2000·Granted Apr 5, 2005·191 cites·58 claims
- 0599US6866850B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Mar 15, 2005·145 cites·80 claims
- 0699US6866849B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Mar 15, 2005·155 cites·60 claims
- 0799US6743427B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Jun 1, 2004·281 cites·19 claims
- 0898US6982084B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Jan 3, 2006·85 cites·34 claims
- 0998US6962707B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Nov 8, 2005·64 cites·42 claims
- 1098US6946135B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Sep 20, 2005·74 cites·60 claims
- 1198US6905686B1Active immunization for treatment of alzheimer's diseaseNEURALAB LTD·Filed 2000·Granted Jun 14, 2005·120 cites·46 claims
- 1298US6890535B1Pharmaceutical compositions and methods for treatment of amyloid diseasesNEURALAB LTD·Filed 2000·Granted May 10, 2005·130 cites·57 claims
- 1398US6787143B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·96 cites·24 claims
- 1498US6787139B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·114 cites·70 claims
- 1598US6787637B1N-Terminal amyloid-β antibodiesNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·202 cites·7 claims
- 1698US6787140B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·111 cites·43 claims
- 1798US6787144B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·116 cites·24 claims
- 1898US6787138B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·113 cites·36 claims
- 1998US6761888B1Passive immunization treatment of Alzheimer's diseaseNEURALAB LTD·Filed 2000·Granted Jul 13, 2004·228 cites·36 claims
- 2098US6750324B1Humanized and chimeric N-terminal amyloid beta-antibodiesNEURALAB LTD·Filed 2000·Granted Jun 15, 2004·202 cites·12 claims
- 2198US6710226B1Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristicsNEURALAB LTD·Filed 2000·Granted Mar 23, 2004·163 cites·32 claims
- 2298US5721130AAntibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of βAPPATHENA NEUROSCIENCES INC·Filed 1995·Granted Feb 24, 1998·244 cites·14 claims
- 2398US5593846AMethods for the detection of soluble β-amyloid peptideATHENA NEUROSCIENCES·Filed 1995·Granted Jan 14, 1997·482 cites·16 claims
- 2498US5441870AMethods for monitoring cellular processing of β-amyloid precursor proteinATHENA NEUROSCIENCES INC·Filed 1992·Granted Aug 15, 1995·316 cites·26 claims
- 2597US7928203B2Chimeric, humanized, or human antibody 2A4ELAN PHARM INC·Filed 2008·Granted Apr 19, 2011·38 cites·3 claims
- 2697US7893214B2Humanized antibodies that recognize beta amyloid peptideJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2007·Granted Feb 22, 2011·41 cites·4 claims
- 2797US6818218B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Nov 16, 2004·58 cites·38 claims
- 2897US6808712B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Oct 26, 2004·53 cites·29 claims
- 2997US6787523B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 1998·Granted Sep 7, 2004·154 cites·24 claims
- 3096US7700751B2Humanized antibodies that recognize β-amyloid peptideJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2007·Granted Apr 20, 2010·38 cites·86 claims
- 3196US6923964B1Active immunization of AScr for prion disordersNEURALAB LTD·Filed 2000·Granted Aug 2, 2005·75 cites·10 claims
- 3296US5605811AMethods and compositions for monitoring cellular processing of beta-amyloid precursor proteinATHENA NEUROSCIENCES INC·Filed 1995·Granted Feb 25, 1997·180 cites·7 claims
- 3396US5604102AMethods of screening for β-amyloid peptide production inhibitorsATHENA NEUROSCIENCES INC·Filed 1993·Granted Feb 18, 1997·165 cites·19 claims
- 3495US8034339B2Prevention and treatment of amyloidogenic diseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2004·Granted Oct 11, 2011·33 cites·41 claims
- 3595US7977316B2Prevention and treatment of amyloidogenic diseasesELAN PHARM INC·Filed 2007·Granted Jul 12, 2011·19 cites·20 claims
- 3695US7575880B1Method of screening an antibody for activity in clearing an amyloid depositELAN PHARMA INT LTD·Filed 2000·Granted Aug 18, 2009·42 cites·4 claims
- 3795US6114133AMethods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)ELAN PHARM INC·Filed 1994·Granted Sep 5, 2000·187 cites·20 claims
- 3895US4745055AFused protein for enzyme immunoassay systemCALIFORNIA BIOTECHNOLOGY INC·Filed 1986·Granted May 17, 1988·115 cites·10 claims
- 3994US8092801B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Jan 10, 2012·44 cites·15 claims
- 4094US7919088B2Treatment and delay of onset of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2007·Granted Apr 5, 2011·40 cites·15 claims
- 4194US7790856B2Humanized antibodies that recognize beta amyloid peptideJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2006·Granted Sep 7, 2010·26 cites·9 claims
- 4294US5837672AMethods and compositions for the detection of soluble β-amyloid peptideATHENA NEUROSCIENCES INC·Filed 1995·Granted Nov 17, 1998·185 cites·14 claims
- 4393US9051363B2Humanized antibodies that recognize beta amyloid peptideBASI GURIQ·Filed 2007·Granted Jun 9, 2015·13 cites·6 claims
- 4493US8147833B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Apr 3, 2012·18 cites·4 claims
- 4593US6284221B1Method for identifying β-amyloid peptide production inhibitorsELAN PHARM INC·Filed 1996·Granted Sep 4, 2001·132 cites·9 claims
- 4693US2025268999A1Treatment and Prophylaxis of AmyloidosisPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4792US8124081B2Prevention and treatment of amyloidogenic diseasesSCHENK DALE B·Filed 2007·Granted Feb 28, 2012·12 cites·22 claims
- 4892US7727957B2Treatment and delay of outset of Parkinson's diseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2003·Granted Jun 1, 2010·44 cites·24 claims
- 4991US8506959B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2005·Granted Aug 13, 2013·13 cites·15 claims
- 5091US8404815B2Chimeric, humanized, or human antibody 2A4SCHENK DALE B·Filed 2011·Granted Mar 26, 2013·8 cites·3 claims
Showing the top 50 of 126 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dale B. Schenk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →